drugset / Trial / NCT01225653

Topical Application of Latanoprost in Diabetic Retinopathy

NCT01225653

RandomizedParallel-groupTriple-blindTreatment

Summary

Randomized double-blinded two-year intervention study with topical application of latanoprost or placebo eye drops in patients with diabetic retinopathy.

Timeline

Start
2010-11
Primary completion
2014-12
Completion
2014-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Latanoprost Small molecule Topical

Indications